Literature DB >> 9495234

Tenascin-C matrix assembly in oral squamous cell carcinoma.

D M Ramos1, B Chen, J Regezi, L Zardi, R Pytela.   

Abstract

We previously showed that the extracellular matrix component tenascin-C (TN-C) is upregulated in oral squamous cell carcinoma (SCC) compared with the normal oral mucosa. In this study we examined oral biopsy specimens of mild to moderate dysplasia or carcinoma in situ to study TN-C expression. We found that carcinoma in situ is the stage at which TN-C becomes widely expressed, suggesting it may be involved in the initial stages of tumor progression. To study TN-C matrix production in vitro, we used an invasive oral SCC cell line (HSC-3) and peri-tumor fibroblasts (PTF). Neither cell type organized a TN-C matrix when cultured alone; however, when co-cultured with HSC-3 cells, PTF were able to assemble a TN-C matrix. PTF retained the ability to organize a TN-C matrix when separated from the HSC-3 cells by a semi-permeable membrane, indicating that cell-cell contact is not necessary for TN-C matrix organization and suggesting that soluble factors may be involved. Moreover, PTF were induced to assemble TN-C matrices when grown in medium conditioned by both the PTF and HSC-3 cells. Antibodies to fibronectin (FN) and to the first FN type III repeat blocked both FN and TN-C matrix assembly, indicating that TN-C matrix organization is dependent on an FN template. Antibodies to alpha5, alphav and beta1 integrins also blocked TN-C matrix formation. When seeded onto FN matrices, the co-cultures were unaffected by the anti-integrin and anti-FN antibodies and were able to organize a TN-C matrix. Our results suggest that progression of malignant oral SCC is accompanied by an alteration of the normal ECM to one rich in TN-C, and that the organization of a TN-C matrix is dependent on soluble cues provided by both the SCC cells and the PTF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9495234     DOI: 10.1002/(sici)1097-0215(19980302)75:5<680::aid-ijc4>3.0.co;2-v

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  High-molecular tenascin-C as an indicator of atypical cells in oral brush biopsies.

Authors:  O Driemel; R Dahse; A Berndt; H Pistner; S G Hakim; L Zardi; T E Reichert; H Kosmehl
Journal:  Clin Oral Investig       Date:  2006-11-17       Impact factor: 3.573

Review 2.  [Oral cytology: historical development, current status, and perspectives].

Authors:  M Hullmann; T E Reichert; R Dahse; F von Eggeling; H Pistner; H Kosmehl; O Driemel
Journal:  Mund Kiefer Gesichtschir       Date:  2007-01

3.  Complex formation of the laminin-5 gamma2 chain and large unspliced tenascin-C in oral squamous cell carcinoma in vitro and in situ: implications for sequential modulation of extracellular matrix in the invasive tumor front.

Authors:  Marcus Franz; Torsten Hansen; Petra Richter; Laura Borsi; Frank-D Böhmer; Peter Hyckel; Peter Schleier; Detlef Katenkamp; Luciano Zardi; Hartwig Kosmehl; Alexander Berndt
Journal:  Histochem Cell Biol       Date:  2005-12-13       Impact factor: 4.304

4.  Identification of novel and distinct binding sites within tenascin-C for soluble and fibrillar fibronectin.

Authors:  Wing S To; Kim S Midwood
Journal:  J Biol Chem       Date:  2011-02-15       Impact factor: 5.157

Review 5.  Tenascin-C and carcinoma cell invasion in oral and urinary bladder cancer.

Authors:  Alexander Berndt; Petra Richter; Hartwig Kosmehl; Marcus Franz
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

6.  Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS.

Authors:  Lang-Ming Chi; Chien-Wei Lee; Kai-Ping Chang; Sheng-Po Hao; Hang-Mao Lee; Ying Liang; Chuen Hsueh; Chia-Jung Yu; I-Neng Lee; Yin-Ju Chang; Shih-Ying Lee; Yuan-Ming Yeh; Yu-Sun Chang; Kun-Yi Chien; Jau-Song Yu
Journal:  Mol Cell Proteomics       Date:  2009-03-18       Impact factor: 5.911

7.  SPARCL1 suppresses metastasis in prostate cancer.

Authors:  Yuzhu Xiang; Qingchao Qiu; Ming Jiang; Renjie Jin; Brian D Lehmann; Douglas W Strand; Bojana Jovanovic; David J DeGraff; Yi Zheng; Dina A Yousif; Christine Q Simmons; Thomas C Case; Jia Yi; Justin M Cates; John Virostko; Xiusheng He; Xunbo Jin; Simon W Hayward; Robert J Matusik; Alfred L George; Yajun Yi
Journal:  Mol Oncol       Date:  2013-07-20       Impact factor: 6.603

8.  β1 integrin: an emerging player in the modulation of tumorigenesis and response to therapy.

Authors:  Grant A Howe; Christina L Addison
Journal:  Cell Adh Migr       Date:  2012-03-01       Impact factor: 3.405

9.  The role of tenascin-C in tissue injury and tumorigenesis.

Authors:  Kim S Midwood; Gertraud Orend
Journal:  J Cell Commun Signal       Date:  2009-10-17       Impact factor: 5.782

10.  Melanoma cell invasiveness is promoted at least in part by the epidermal growth factor-like repeats of tenascin-C.

Authors:  Jelena Grahovac; Dorothea Becker; Alan Wells
Journal:  J Invest Dermatol       Date:  2012-09-06       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.